CHDI
Pharmaceutical ManufacturingUnited States11-50 Employees
CHDI is a United States–based organization operating in pharmaceutical manufacturing with a focus on Huntington’s disease research and therapeutic development. The group collaborates with partners to advance biomarkers and endpoints that can improve clinical trials and translational efforts, including precision eye movement biomarkers and other data-driven endpoints. Its activities are centered on supporting the development of therapeutics for Huntington’s disease, aiming to better understand disease progression and to refine trial design. CHDI is part of a broader ecosystem of biomedical research organizations and collaborates with technology partners and industry groups to enhance translational biology and regulatory science related to Huntington’s disease. The organization is active in partnerships and joint analyses, evidenced by recent collaborations and participation in data-collection initiatives and interdisciplinary projects within the HD research community. CHDI is based in the United States and operates with a focus on advancing science and therapeutics for HD through collaborative research and methodological development.
1-888-653-2347 
support@leadiq.com 
